BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q1 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $695,493 | -7.7% | 17,990 | -9.9% | 0.02% | -9.5% |
Q3 2023 | $753,479 | -31.2% | 19,965 | -17.0% | 0.02% | -22.2% |
Q2 2023 | $1,095,718 | +8.9% | 24,050 | -3.1% | 0.03% | -3.6% |
Q1 2023 | $1,006,415 | -37.5% | 24,813 | -21.5% | 0.03% | -39.1% |
Q4 2022 | $1,610,193 | +1.8% | 31,591 | +7.6% | 0.05% | -11.5% |
Q3 2022 | $1,582,000 | +10.6% | 29,370 | +31.9% | 0.05% | +23.8% |
Q2 2022 | $1,430,000 | -26.3% | 22,266 | -11.0% | 0.04% | +7.7% |
Q1 2022 | $1,940,000 | -7.8% | 25,024 | +2.1% | 0.04% | -4.9% |
Q4 2021 | $2,103,000 | -9.4% | 24,499 | -15.2% | 0.04% | -30.5% |
Q3 2021 | $2,322,000 | -8.5% | 28,875 | -8.4% | 0.06% | -26.2% |
Q2 2021 | $2,537,000 | -1.1% | 31,520 | +3.7% | 0.08% | -16.7% |
Q1 2021 | $2,564,000 | +68.0% | 30,401 | +59.9% | 0.10% | +35.2% |
Q4 2020 | $1,526,000 | +105.4% | 19,017 | +105.9% | 0.07% | +69.0% |
Q3 2020 | $743,000 | -67.6% | 9,238 | -65.3% | 0.04% | -88.9% |
Q2 2020 | $2,293,000 | +2216.2% | 26,636 | +2081.5% | 0.38% | +603.7% |
Q1 2020 | $99,000 | +57.1% | 1,221 | +61.5% | 0.05% | +315.4% |
Q4 2019 | $63,000 | – | 756 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 298,721 | $23,969,000 | 8.70% |
GENERATION INVESTMENT MANAGEMENT LLP | 17,424,560 | $1,398,147,000 | 6.24% |
Soditic Asset Management LLP | 77,950 | $6,255,000 | 6.24% |
Veritas Asset Management LLP | 11,110,132 | $891,477,000 | 5.32% |
Dash Acquisitions Inc. | 84,560 | $6,785,000 | 4.74% |
Prosight Management, LP | 121,075 | $9,715,000 | 4.49% |
TSFG, LLC | 94,977 | $7,621,000 | 4.07% |
CINCINNATI FINANCIAL CORP | 1,344,648 | $107,895,000 | 2.93% |
Dundas Partners LLP | 204,535 | $19,304,000 | 2.82% |
Unified Trust Company, N.A. | 59,491 | $4,689,000 | 2.72% |